{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:53:11Z","timestamp":1790239991343,"version":"4.1.0"},"reference-count":23,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"published-print":{"date-parts":[[2018,8,1]]},"DOI":"10.1001\/jamapediatrics.2018.1307","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T20:19:46Z","timestamp":1529353186000},"page":"741","source":"Crossref","is-referenced-by-count":90,"title":["Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome"],"prefix":"10.1001","volume":"172","author":[{"given":"Jonathan M.","family":"Davis","sequence":"first","affiliation":[{"name":"Department of Pediatrics, The Floating Hospital for Children at Tufts Medical Center, Boston, Massachusetts"},{"name":"Tufts Clinical and Translational Science Institute, Tufts University, Boston, Massachusetts"},{"name":"The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Shenberger","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Baystate Medical Center, Springfield, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma","family":"Terrin","sequence":"additional","affiliation":[{"name":"Tufts Clinical and Translational Science Institute, Tufts University, Boston, Massachusetts"},{"name":"The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janis L.","family":"Breeze","sequence":"additional","affiliation":[{"name":"Tufts Clinical and Translational Science Institute, Tufts University, Boston, Massachusetts"},{"name":"The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hudak","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Jacksonville\u2013University of Florida Health, Jacksonville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisha M.","family":"Wachman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Marro","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Maine Medical Center, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica L.","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Women and Infant\u2019s Hospital, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Harvey-Wilkes","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Floating Hospital for Children at Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Czynski","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Women and Infant\u2019s Hospital, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Engelhardt","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Monroe Carell Jr Children's Hospital at Vanderbilt, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"D\u2019Apolito","sequence":"additional","affiliation":[{"name":"Vanderbilt University School of Nursing, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Bogen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Lester","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Women and Infant\u2019s Hospital, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"24","key":"poi180029r1","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure.","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"issue":"8","key":"poi180029r2","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/jp.2015.36","article-title":"Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012.","volume":"35","author":"Patrick","year":"2015","journal-title":"J Perinatol"},{"issue":"3","key":"poi180029r3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1053\/j.semperi.2015.12.007","article-title":"Neonatal abstinence syndrome: Pharmacologic strategies for the mother and infant.","volume":"40","author":"Kraft","year":"2016","journal-title":"Semin Perinatol"},{"issue":"1","key":"poi180029r4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5055\/jom.2009.0006","article-title":"The opioid-exposed newborn: assessment and pharmacologic management.","volume":"5","author":"Jansson","year":"2009","journal-title":"J Opioid Manag"},{"issue":"2","key":"poi180029r5","doi-asserted-by":"publisher","first-page":"e540","DOI":"10.1542\/peds.2011-3212","article-title":"Neonatal drug withdrawal.","volume":"129","author":"Hudak","year":"2012","journal-title":"Pediatrics"},{"issue":"4","key":"poi180029r6","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/jp.2014.194","article-title":"Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial.","volume":"35","author":"Brown","year":"2015","journal-title":"J Perinatol"},{"key":"poi180029r7","article-title":"Morphine versus methadone treatment for neonatal withdrawal and impact on early infant development","author":"Burke","journal-title":"Glob Pediatr Health"},{"issue":"23","key":"poi180029r8","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.2146\/sp150025","article-title":"Retrospective chart review comparing morphine and methadone in neonates treated for neonatal abstinence syndrome.","volume":"72","author":"Young","year":"2015","journal-title":"Am J Health Syst Pharm"},{"issue":"7","key":"poi180029r9","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1053\/j.semperi.2015.08.013","article-title":"Opioids in pregnancy and neonatal abstinence syndrome.","volume":"39","author":"Stover","year":"2015","journal-title":"Semin Perinatol"},{"issue":"3","key":"poi180029r10","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/JPN.0000000000000056","article-title":"Assessing neonates for neonatal abstinence: are you reliable?","volume":"28","author":"D'Apolito","year":"2014","journal-title":"J Perinat Neonatal Nurs"},{"issue":"10","key":"poi180029r12","first-page":"CD002059","article-title":"Opiate treatment for opiate withdrawal in newborn infants.","volume":"10","author":"Osborn","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"poi180029r13","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/jp.2014.114","article-title":"Variation in treatment of neonatal abstinence syndrome in US children\u2019s hospitals, 2004-2011.","volume":"34","author":"Patrick","year":"2014","journal-title":"J Perinatol"},{"issue":"3","key":"poi180029r14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.drugalcdep.2012.11.019","article-title":"Cigarette smoking in opioid-dependent pregnant women: neonatal and maternal outcomes.","volume":"131","author":"Jones","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"poi180029r15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/add.2012.107.issue-s1","article-title":"Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.","volume":"107","author":"Kaltenbach","year":"2012","journal-title":"Addiction"},{"issue":"6","key":"poi180029r16","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.phrs.2004.05.002","article-title":"Methadone\u2014metabolism, pharmacokinetics and interactions.","volume":"50","author":"Ferrari","year":"2004","journal-title":"Pharmacol Res"},{"issue":"6","key":"poi180029r17","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/pan.2014.24.issue-6","article-title":"The pharmacokinetics of methadone and its metabolites in neonates, infants, and children.","volume":"24","author":"Ward","year":"2014","journal-title":"Paediatr Anaesth"},{"issue":"6","key":"poi180029r18","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.jpeds.2015.09.038","article-title":"Cohort analysis of a pharmacokinetic-modeled methadone weaning optimization for neonatal abstinence syndrome.","volume":"167","author":"Hall","year":"2015","journal-title":"J Pediatr"},{"issue":"6","key":"poi180029r19","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jpeds.2015.08.032","article-title":"Pharmacokinetics of oral methadone in the treatment of neonatal abstinence syndrome: a pilot study.","volume":"167","author":"Wiles","year":"2015","journal-title":"J Pediatr"},{"issue":"12","key":"poi180029r20","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/jp.2013.95","article-title":"Efficacy of clonidine versus phenobarbital in reducing neonatal morphine sulfate therapy days for neonatal abstinence syndrome: a prospective randomized clinical trial.","volume":"33","author":"Surran","year":"2013","journal-title":"J Perinatol"},{"issue":"24","key":"poi180029r21","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1056\/NEJMoa1614835","article-title":"Buprenorphine for the treatment of the neonatal abstinence syndrome.","volume":"376","author":"Kraft","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"poi180029r22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ijpharm.2017.07.042","article-title":"Challenges and strategies to facilitate formulation development of pediatric drug products: Safety qualification of excipients.","volume":"536","author":"Buckley","year":"2018","journal-title":"Int J Pharm"},{"issue":"9","key":"poi180029r23","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1111\/add.v112.9","article-title":"The economic burden of neonatal abstinence syndrome in the United States.","volume":"112","author":"Corr","year":"2017","journal-title":"Addiction"},{"key":"poi180029r11","unstructured":"D\u2019ApolitoK, FinneganL. Assessing signs and symptoms of neonatal abstinence using the Finnegan Scoring Tool: an inter-observer reliability program, NeoAdvances.com. 2010. https:\/\/www.neoadvances.com\/. Accessed May 1, 2018."}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2685283","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T15:50:21Z","timestamp":1533570621000},"score":1,"resource":{"primary":{"URL":"http:\/\/archpedi.jamanetwork.com\/article.aspx?doi=10.1001\/jamapediatrics.2018.1307"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2018,8,1]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2018.1307","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8,1]]}}}